tirzepatide original name New Blockbuster Type 2 Medication Mounjaro Gets FDA Approval F.D.A. Approves New Obesity Drug

But at the same time, the patent cliff is at this point the least of Novo Nordisk's worries, given what the competition looks like

All three medications share semaglutide as their active ingredient and belong to the glucagon-like peptide-1 (GLP-1) agonist family

Most health insurance policies typically cover Semaglutide, but the extent of coverage and the out-of-pocket expenses varies from plan to plan

The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two years

how should I manage them?

One approach to mitigating the effects of these errors is to emulate a target trial (i.e., the hypothetical trial of interest)